Cited by 441

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL

Brown, Michael S., Goldstein, Joseph L.·2009·Journal of Lipid Research

Abstract

Cholesterol biosynthesis is among the most intensely regulated processes in biology. Synthetic rates vary over hundreds of fold depending on the availability of an external source of cholesterol. Studies of this feedback regulatory process have a rich history. The field began 75 years ago when Rudolf Schoenheimer measured cholesterol balance in mice in a bottle. He found that cholesterol feeding led to decreased cholesterol synthesis, thereby introducing the general phenomenon by which end products of biosynthetic pathways inhibit their own synthesis. Recently, cholesterol feedback has been explained at a molecular level with the discovery of membrane-bound transcription factors called sterol regulatory element-binding proteins (SREBPs), and an appreciation of the sterol-sensing role of their partner, an escort protein called Scap. The key element in Scap is a hexapeptide sequence designated MELADL (rhymes with bottle). Thus, over 75 years, Schoenheimer's bottle led to Scap's MELADL. In addition to their basic importance in membrane biology, these studies have implications for the regulation of plasma cholesterol levels and consequently for the development of atherosclerotic plaques, myocardial infarctions, and strokes. In this article we review the major milestones in the cholesterol feedback story.

Overview

Integrity signals

Registry

Crossref · 10.1194/jlr.r800054-jlr200

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 25-Hydroxycholesterol is a potent oxysterol regulator of cholesterol biosynthesis.

    “25-hydroxycholesterol (25-HC) is a potent oxysterol regulator of cholesterol biosynthesis [44–46].”
  • Upstream regulators SREBF2 and SCAP are activated, but POR is inhibited in both APOE4 microglia and astrocytes.

    “Upstream regulators, transcription factors regulating cholesterol synthesis, SREBF2 and SCAP, are activated, but POR (Cytochrome P450 oxidoreductase) is inhibited in both APOE4 microglia and astrocytes (Figure 2H)(Brown and Goldstein, 2009; Schmidt et al., 2009).”

    From Cholesterol and matrisome pathways dysregulated in astrocytes and microglia (2022) · cites this paper as Brown and Goldstein, 2009

  • Elevated gene sets and enzymes of cholesterol synthesis in APOE4 human astrocytes contradict the mechanism by which increased free cholesterol levels suppress gene expression via SREBP2.

    “Elevated gene sets and enzymes of cholesterol synthesis in APOE4 human astrocytes contradict the mechanism by which increased free cholesterol levels suppress gene expression via SREBP2 (Brown and Goldstein, 2009).”

    From Cholesterol and matrisome pathways dysregulated in astrocytes and microglia (2022) · cites this paper as Brown and Goldstein, 2009

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 105

  1. Schoenheimer, 1933, Synthesis and destruction of cholesterol in the organism, J. Biol. Chem., 103, 439, 10.1016/S0021-9258(18)75823-7 · DOI
  2. Jacob, 1961, On the regulation of gene activity, Cold Spring Harb. Symp. Quant. Biol., 26, 193, 10.1101/SQB.1961.026.01.024 · DOI
  3. Bloch, 1965, The biological synthesis of cholesterol, Science., 50, 19, 10.1126/science.150.3692.19 · DOI
  4. Gould, 1953, Cholesterol metabolism: I. Effect of dietary cholesterol on the synthesis of cholesterol in dog tissue in vitro, J. Biol. Chem., 201, 519, 10.1016/S0021-9258(18)66206-4 · DOI
  5. Spady, 1983, Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat, J. Lipid Res., 24, 303, 10.1016/S0022-2275(20)37999-2 · DOI
  6. Goldstein, 1973, Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol, Proc. Natl. Acad. Sci. USA., 70, 2804, 10.1073/pnas.70.10.2804 · DOI · Paper page
  7. Goldstein, 1979, Coated pits, coated vesicles, and receptor-mediated endocytosis, Nature., 279, 679, 10.1038/279679a0 · DOI · Paper page
  8. Brown, 1975, Regulation of the activity of the low density lipoprotein receptor in human fibroblasts, Cell., 6, 307, 10.1016/0092-8674(75)90182-8 · DOI
  9. Goldstein, 1984, Progress in understanding the LDL receptor and HMG CoA reductase, two membrane proteins that regulate the plasma cholesterol, J. Lipid Res., 25, 1450, 10.1016/S0022-2275(20)34418-7 · DOI
  10. Chin, 1981, Evidence for coordinate expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein binding activity, J. Biol. Chem., 256, 6304, 10.1016/S0021-9258(19)69163-5 · DOI
  11. Schneider, 1982, Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight, J. Biol. Chem., 257, 2664, 10.1016/S0021-9258(18)34975-5 · DOI · Paper page
  12. Yamamoto, 1984, The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA, Cell., 39, 27, 10.1016/0092-8674(84)90188-0 · DOI · Paper page
  13. Sudhof, 1985, The LDL receptor gene: a mosaic of exons shared with different proteins, Science., 228, 815, 10.1126/science.2988123 · DOI · Paper page
  14. Schimke, 1978, Gene amplification and drug resistance in cultured murine cells, Science., 202, 1051, 10.1126/science.715457 · DOI
  15. Endo, 1976, Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity, FEBS Lett., 72, 323, 10.1016/0014-5793(76)80996-9 · DOI
  16. Chin, 1982, Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold elevation in 3-hydroxy-3-methylglutaryl CoA reductase, Proc. Natl. Acad. Sci. USA., 79, 1185, 10.1073/pnas.79.4.1185 · DOI
  17. Chin, 1982, Molecular cloning of 3-hydroxy-3-methylglutaryl coenzyme A reductase and evidence for regulation of its mRNA in UT-1 cells, Proc. Natl. Acad. Sci. USA., 79, 7704, 10.1073/pnas.79.24.7704 · DOI
  18. Gil, 1986, Cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme A synthase from the hamster: I. Isolation and sequencing of a full-length cDNA, J. Biol. Chem., 261, 3710, 10.1016/S0021-9258(17)35705-8 · DOI
  19. Liscum, 1985, Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum, J. Biol. Chem., 260, 522, 10.1016/S0021-9258(18)89764-2 · DOI
  20. Roitelman, 1992, Immunological evidence for eight spans in the membrane domain of 3-hydroxy-3-methylglutaryl Coenzyme A reductase: implications for enzyme degradation in the endoplasmic reticulum, J. Cell Biol., 117, 959, 10.1083/jcb.117.5.959 · DOI
  21. Gil, 1985, Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme, Cell., 41, 249, 10.1016/0092-8674(85)90078-9 · DOI
  22. Nakanishi, 1988, Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase: mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme, J. Biol. Chem., 263, 8929, 10.1016/S0021-9258(18)68397-8 · DOI
  23. Metherall, 1989, Loss of transcriptional repression of three sterol-regulated genes in mutant hamster cells, J. Biol. Chem., 264, 15634, 10.1016/S0021-9258(19)84879-2 · DOI
  24. Kandutsch, 1974, Inhibition of sterol synthesis in cultured mouse cells by cholesterol derivatives oxygenated in the side chain, J. Biol. Chem., 249, 6057, 10.1016/S0021-9258(19)42218-7 · DOI · Paper page
  25. Brown, 1974, Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol, J. Biol. Chem., 249, 7306, 10.1016/S0021-9258(19)42106-6 · DOI · Paper page
  26. Reynolds, 1984, HMG CoA reductase: a negatively regulated gene with unusual promoter and 5′ untranslated regions, Cell., 38, 275, 10.1016/0092-8674(84)90549-X · DOI
  27. Sudhof, 1987, 42-bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter, Cell., 48, 1061, 10.1016/0092-8674(87)90713-6 · DOI · Paper page
  28. Smith, 1990, Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene, J. Biol. Chem., 265, 2306, 10.1016/S0021-9258(19)39976-4 · DOI · Paper page
  29. Wang, 1993, Nuclear protein that binds sterol regulatory element of LDL receptor promoter: II. Purification and characterization, J. Biol. Chem., 268, 14497, 10.1016/S0021-9258(19)85266-3 · DOI · Paper page
  30. Yokoyama, 1993, SREBP-1, a basic helix-loop-helix leucine zipper protein that controls transcription of the LDL receptor gene, Cell., 75, 187, 10.1016/S0092-8674(05)80095-9 · DOI
  31. Kim, 1995, Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain, Mol. Cell. Biol., 15, 2582, 10.1128/MCB.15.5.2582 · DOI
  32. Parraga, 1998, Co-crystal structure of sterol regulatory element binding protein 1a at 2.3 A resolution, Structure., 6, 661, 10.1016/S0969-2126(98)00067-7 · DOI
  33. Hua, 1993, SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element, Proc. Natl. Acad. Sci. USA., 90, 11603, 10.1073/pnas.90.24.11603 · DOI · Paper page
  34. Shimomura, 1997, Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells, J. Clin. Invest., 99, 838, 10.1172/JCI119247 · DOI
  35. Tontonoz, 1993, ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation, Mol. Cell. Biol., 13, 4753
  36. Kim, 1996, ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism, Genes Dev., 10, 1096, 10.1101/gad.10.9.1096 · DOI
  37. Shimano, 1997, Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells, J. Clin. Invest., 99, 846, 10.1172/JCI119248 · DOI · Paper page
  38. Wang, 1994, SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis, Cell., 77, 53, 10.1016/0092-8674(94)90234-8 · DOI
  39. Hua, 1996, Regulated cleavage of sterol regulatory element binding proteins (SREBPs) requires sequences on both sides of the endoplasmic reticulum membrane, J. Biol. Chem., 271, 10379, 10.1074/jbc.271.17.10379 · DOI
  40. Nohturfft, 1998, Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain, J. Biol. Chem., 273, 17243, 10.1074/jbc.273.27.17243 · DOI
  41. Sakai, 1996, Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment, Cell., 85, 1037, 10.1016/S0092-8674(00)81304-5 · DOI · Paper page
  42. Duncan, 1998, Second-site cleavage in sterol regulatory element-binding protein occurs at transmembrane junction as determined by cysteine panning, J. Biol. Chem., 273, 17801, 10.1074/jbc.273.28.17801 · DOI · Paper page
  43. Brown, 2000, Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell., 100, 391, 10.1016/S0092-8674(00)80675-3 · DOI · Paper page
  44. Rawson, 1997, Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs, Mol. Cell., 1, 47, 10.1016/S1097-2765(00)80006-4 · DOI · Paper page
  45. Zelenski, 1999, Membrane topology of S2P, a protein required for intramembranous cleavage of sterol regulatory element-binding proteins, J. Biol. Chem., 274, 21973, 10.1074/jbc.274.31.21973 · DOI
  46. Rudner, 1999, A family of membrane-embedded metalloproteases involved in regulated proteolysis of membrane-associated transcription factors, Proc. Natl. Acad. Sci. USA., 96, 14765, 10.1073/pnas.96.26.14765 · DOI
  47. Feng, 2007, Structure of a Site-2 protease family intramembrane metalloprotease, Science., 318, 1608, 10.1126/science.1150755 · DOI
  48. Chang, 1982, Revertants of a Chinese hamster ovary cell mutant resistant to suppression by an analogue of cholesterol: isolation and partial biochemical characterization, Biochemistry., 21, 5316, 10.1021/bi00264a030 · DOI
  49. Rawson, 1998, Isolation of cholesterol-requiring mutant CHO cells with defects in cleavage of sterol regulatory element binding proteins at Site-1, J. Biol. Chem., 273, 28261, 10.1074/jbc.273.43.28261 · DOI
  50. Sakai, 1998, Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells, Mol. Cell., 2, 505, 10.1016/S1097-2765(00)80150-1 · DOI
  51. Hua, 1996, Sterol resistance in CHO cells traced to point mutation in SREBP cleavage activating protein (SCAP), Cell., 87, 415, 10.1016/S0092-8674(00)81362-8 · DOI · Paper page
  52. Nohturfft, 1998, Sterols regulate processing of carbohydrate chains of wild-type SREBP cleavage-activating protein (SCAP), but not sterol-resistant mutants Y298C or D443N, Proc. Natl. Acad. Sci. USA., 95, 12848, 10.1073/pnas.95.22.12848 · DOI
  53. Sakai, 1997, Identification of complexes between the COOH-terminal domains of sterol regulatory element binding proteins (SREBPs) and SREBP cleavage-activating protein (SCAP), J. Biol. Chem., 272, 20213, 10.1074/jbc.272.32.20213 · DOI · Paper page
  54. Sakai, 1998, Cleavage of sterol regulatory element binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies, J. Biol. Chem., 273, 5785, 10.1074/jbc.273.10.5785 · DOI
  55. Nohturfft, 2000, Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes, Cell., 102, 315, 10.1016/S0092-8674(00)00037-4 · DOI
  56. Espenshade, 1999, Autocatalytic processing of Site-1 protease removes propeptide and permits cleavage of sterol regulatory element-binding proteins, J. Biol. Chem., 274, 22795, 10.1074/jbc.274.32.22795 · DOI · Paper page
  57. Brown, 1997, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell., 89, 331, 10.1016/S0092-8674(00)80213-5 · DOI · Paper page
  58. Yang, 2000, Overexpression of membrane domain of SCAP prevents sterols from inhibiting SCAP/SREBP exit from endoplasmic reticulum, J. Biol. Chem., 275, 29881, 10.1074/jbc.M005439200 · DOI
  59. Yang, 2002, Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER, Cell., 110, 489, 10.1016/S0092-8674(02)00872-3 · DOI · Paper page
  60. Diamond, 1993, Novel delayed-early and highly insulin-induced growth response genes: identification of HRS, a potential regulator of alternative pre-mRNA splicing, J. Biol. Chem., 268, 15185, 10.1016/S0021-9258(18)82454-1 · DOI · Paper page
  61. Yabe, 2002, Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins, Proc. Natl. Acad. Sci. USA., 99, 12753, 10.1073/pnas.162488899 · DOI · Paper page
  62. Adams, 2004, Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs, J. Biol. Chem., 279, 52772, 10.1074/jbc.M410302200 · DOI
  63. Lee, 2005, Isolation of sterol-resistant Chinese hamster ovary cells with genetic deficiencies in both Insig-1 and Insig-2, J. Biol. Chem., 280, 25242, 10.1074/jbc.M502989200 · DOI
  64. Brown, 2002, Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism, Mol. Cell., 10, 237, 10.1016/S1097-2765(02)00591-9 · DOI · Paper page
  65. Radhakrishnan, 2004, Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain, Mol. Cell., 15, 259, 10.1016/j.molcel.2004.06.019 · DOI · Paper page
  66. Dawson, 1989, Purification of oxysterol binding protein from hamster liver cytosol, J. Biol. Chem., 264, 9046, 10.1016/S0021-9258(18)81900-7 · DOI
  67. Dawson, 1989, cDNA cloning and expression of oxysterol binding protein, an oligomer with a potential leucine zipper, J. Biol. Chem., 264, 16798, 10.1016/S0021-9258(19)84776-2 · DOI
  68. Dobrosotskaya, 2003, Reconstitution of sterol-regulated endoplasmic reticulum-to-Golgi transport of SREBP-2 in insect cells by co-expression of mammalian SCAP and insigs, J. Biol. Chem., 278, 35837, 10.1074/jbc.M306476200 · DOI
  69. Kunte, 2006, Fatty acid auxotrophy in Drosophila larvae lacking SREBP, Cell Metab., 3, 439, 10.1016/j.cmet.2006.04.011 · DOI
  70. Radhakrishnan, 2007, Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig, Proc. Natl. Acad. Sci. USA., 104, 6511, 10.1073/pnas.0700899104 · DOI · Paper page
  71. Antonny, 2001, ER export: public transportation by the COPII coach, Curr. Opin. Cell Biol., 13, 438, 10.1016/S0955-0674(00)00234-9 · DOI
  72. Bannykh, 1998, Getting into the Golgi, Trends Cell Biol., 8, 21, 10.1016/S0962-8924(97)01184-7 · DOI
  73. Rothman, 1992, Molecular dissection of the secretory pathway, Nature., 355, 409, 10.1038/355409a0 · DOI
  74. Espenshade, 2002, Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER, Proc. Natl. Acad. Sci. USA., 99, 11694, 10.1073/pnas.182412799 · DOI · Paper page
  75. Sun, 2005, Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro, J. Biol. Chem., 280, 26483, 10.1074/jbc.M504041200 · DOI · Paper page
  76. Sun, 2007, Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins, Proc. Natl. Acad. Sci. USA., 104, 6519, 10.1073/pnas.0700907104 · DOI
  77. Radhakrishnan, 2008, Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance, Cell Metab., 8, 512, 10.1016/j.cmet.2008.10.008 · DOI · Paper page
  78. Gong, 2006, Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake, Cell Metab., 3, 15, 10.1016/j.cmet.2005.11.014 · DOI · Paper page
  79. Lee, 2006, Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78, J. Biol. Chem., 281, 39308, 10.1074/jbc.M608999200 · DOI
  80. Lee, 2006, Proteasomal degradation of ubiquitinated Insig proteins is determined by serine residues flanking ubiquitinated lysines, Proc. Natl. Acad. Sci. USA., 103, 4958, 10.1073/pnas.0600422103 · DOI
  81. Engelking, 2004, Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis, J. Clin. Invest., 113, 1168, 10.1172/JCI20978 · DOI · Paper page
  82. Yabe, 2003, Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis, Proc. Natl. Acad. Sci. USA., 100, 3155, 10.1073/pnas.0130116100 · DOI
  83. Skalnik, 1988, The membrane domain of 3-hydroxy-3-methylglutaryl-coenzyme A reductase confers endoplasmic reticulum localization and sterol-regulated degradation onto β-galactosidase, J. Biol. Chem., 263, 6836, 10.1016/S0021-9258(18)68719-8 · DOI
  84. Sever, 2004, Isolation of mutant cells lacking Insig-1 through selection with SR-12813, an agent that stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, J. Biol. Chem., 279, 43136, 10.1074/jbc.M406406200 · DOI
  85. Sever, 2003, Accelerated degradation of HMG CoA reductase mediated by binding of Insig-1 to its sterol-sensing domain, Mol. Cell., 11, 25, 10.1016/S1097-2765(02)00822-5 · DOI
  86. Goldstein, 2006, Protein sensors for membrane sterols, Cell., 124, 35, 10.1016/j.cell.2005.12.022 · DOI · Paper page
  87. Song, 2004, Ubiquitination of 3-hydroxy-3-methylglutaryl-CoA reductase in permeabilized cells mediated by cytosolic E1 and a putative membrane-bound ubiquitin ligase, J. Biol. Chem., 279, 28798, 10.1074/jbc.M402442200 · DOI
  88. Shearer, 2005, Lipid-mediated, reversible misfolding of a sterol-sensing domain protein, EMBO J., 24, 149, 10.1038/sj.emboj.7600498 · DOI
  89. Song, 2005, Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol, Cell Metab., 1, 179, 10.1016/j.cmet.2005.01.001 · DOI
  90. Lange, 2008, Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methlglutaryl-CoA reductase, J. Biol. Chem., 283, 1445, 10.1074/jbc.M706967200 · DOI
  91. Sever, 2003, Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol, J. Biol. Chem., 278, 52479, 10.1074/jbc.M310053200 · DOI
  92. Brown, 2008, Selective vs. total insulin resistance: a pathogenic paradox, Cell Metab., 7, 95, 10.1016/j.cmet.2007.12.009 · DOI
  93. Horton, 1998, Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2, J. Clin. Invest., 101, 2331, 10.1172/JCI2961 · DOI
  94. Korn, 1998, Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N), J. Clin. Invest., 102, 2050, 10.1172/JCI5341 · DOI · Paper page
  95. Engelking, 2005, Schoenheimer effect explained - Feedback regulation of cholesterol synthesis in mice mediated by Insig proteins, J. Clin. Invest., 115, 2489, 10.1172/JCI25614 · DOI · Paper page
  96. Matsuda, 2001, SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation, Genes Dev., 15, 1206, 10.1101/gad.891301 · DOI · Paper page
  97. Yang, 2001, Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene, Proc. Natl. Acad. Sci. USA., 98, 13607, 10.1073/pnas.201524598 · DOI · Paper page
  98. Gould, 1951, Lipid metabolism and atherosclerosis, Am. J. Med., 11, 209, 10.1016/0002-9343(51)90107-6 · DOI
  99. Tomkins, 1953, Cholesterol synthesis by liver: III. Its regulation by ingested cholesterol, J. Biol. Chem., 201, 137, 10.1016/S0021-9258(18)71355-0 · DOI
  100. Langdon, 1953, The effect of some dietary additions on the synthesis of cholesterol from acetate in vitro, J. Biol. Chem., 202, 77, 10.1016/S0021-9258(19)57108-3 · DOI
  101. Frantz, 1954, Suppression of hepatic cholesterol synthesis in the rat by cholesterol feeding, J. Biol. Chem., 206, 465, 10.1016/S0021-9258(18)71338-0 · DOI
  102. Bucher, 1959, Cholesterol biosynthesis in preparations of liver from normal, fasting, x–irradiated, cholesterol-fed, Triton, or 44-cholesten-3-one-treated rats, J. Biol. Chem., 234, 262, 10.1016/S0021-9258(18)70285-8 · DOI
  103. Siperstein, 1960, Studies on the site of the feedback control of cholesterol synthesis, J. Clin. Invest., 39, 642, 10.1172/JCI104079 · DOI
  104. Linn, 1967, The effect of cholesterol feeding and fasting upon β-hydroxy-β-methylglutaryl coenzyme A reductase, J. Biol. Chem., 242, 990, 10.1016/S0021-9258(18)96221-6 · DOI
  105. Shapiro, 1971, Regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol synthesis, J. Biol. Chem., 246, 3210, 10.1016/S0021-9258(18)62216-1 · DOI

Cited by

Sorted by citations

Metadata

Authors
Brown, M. S., & Goldstein, J. L.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2009-04
Volume
50
Pages
S15-S27
ISSN
0022-2275
Cited by
441
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review